💊 Medicamentos A-Z 🧬 Alvos 🛠 Ferramentas 📚 Guias
Todos os Medicamentos Classes de Medicamentos Áreas Terapêuticas Efeitos Colaterais
Guias Glossário Linha do Tempo
Comparações Percursos de Medicamentos Famílias de Medicamentos
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Sermorelin Acetate

CHEMBL1201490 Phase 4 Aprovado Protein
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
— g/mol
LogP
—
Phase
4

Sermorelin acetate is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) consisting of the first 29 amino acids of the 44-amino acid endogenous peptide, used to diagnose growth hormone deficiency and as a growth-promoting therapy in children with idiopathic growth hormone deficiency. By binding to GHRH receptors on somatotroph cells in the anterior pituitary, it stimulates pulsatile growth hormone secretion, preserving the physiological regulation of the GH-IGF-1 axis. Unlike exogenous GH, it does not suppress endogenous GH secretion.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

Sermorelin acetate is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) consisting of the first 29 amino acids of the 44-amino acid endogenous peptide, used to diagnose growth hormone deficiency and as a growth-promoting therapy in children with idiopathic growth hormone deficiency. By binding to GHRH receptors on somatotroph cells in the anterior pituitary, it stimulates pulsatile growth hormone secretion, preserving the physiological regulation of the GH-IGF-1 axis. Unlike exogenous GH, it does not suppress endogenous GH secretion.

Yes, Sermorelin Acetate is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201490. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.